Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: caney and all, re problems with Leckrone.....
4
Aug 05, 2011 04:49PM
4
Aug 05, 2011 04:57PM

<u really think that tpl did not need the other 50% of the mmp?.......>

Yes. Both companies were able to sell licenses w/o the other and did.

<and tpl went into the agreement with ptsc for what purpose?>

Probably for more than one reason. First to end the litigation and risk that comes with it, to avoid a price war with PTSC and the favorable terms of the MA. Doubt anyone here would argue that the MA terms favored TPL. Water under the bridge at this point. Hopefully a new agreement or dissolution of the present one will resolve that issue.

Opty

7
Aug 12, 2011 11:51AM
Share
New Message
Please login to post a reply